PepSee goes public — a new software tool for therapeutic peptide analysis & design

webinar

Thu, 25 Jan 2018, 16:00 CET (Berlin)

Dr. Marcus Gastreich, BioSolveIT GmbH, St. Augustin, Germany

PepSee goes public — a new software tool for therapeutic peptide analysis & design

In collaboration with Zealand Pharma, a leading and experienced therapeutic peptide specialist in Copenhagen, we conceived a tool with the major focus of having it rolled-out and operational ASAP, targeting the most relevant problems and most ugly time-eaters first thus boosting the efficiency of the organization. After approx. 2 years, we can now roll out the tool in its current status to the general public, and academics can use it for free.

PepSee sports, amongst others:

  • visual pattern recognition support for SAR work
  • versatile colorings, for ex. by mutation differences to a reference peptide
  • a plethora of sorting and filtering facilities
  • FASTA, PLN, and TXT import
  • XLS export
  • on-the-fly alignment including manual intervention
  • interfaces to predictive methods such as fibrillation highlighting, and allows validation and registration of new sequences
  • A first PDF text mining function pulling peptides from patents et al.

Current news

category
Events
Recordings of the BioSolveIT Day 2025 Available
October 15, 2025 13:39 CEST
Missed BioSolveIT Day 2025? The recordings from BioSolveIT Day 2025 are now live! Packed with practical insights for medicinal and computational chemists, the sessions showcase how SeeSAR, infiniSee, Chemical Space Docking®, and CoLibri accelerate real-world discovery, from pocket-aware design and HYDE-guided decisions to trillion-scale, synthesizable chemical space exploration and in-house...
Read on
Enamine’s REAL Space September 2025 Update - Now 83 Billion!
September 23, 2025 10:31 CEST
The September 2025 update of Enamine’s REAL Space brings a new expansion, now featuring over 83 billion accessible, drug-like products, up from 76 billion in the previous release. Built from 172 curated reactions and 192,487 reagents and building blocks based on in-house knowledge, this version further enhances one of the...
Read on
WuXi’s GalaXi Space September 2025 – Expanded to 26 Billion Molecules!
September 17, 2025 10:03 CEST
The September 2025 update of WuXi LabNetwork’s GalaXi Space delivers a major expansion, now featuring over 25.8 billion synthesis-ready products. Built from 185 curated reactions and 30,877 high-quality building blocks, GalaXi is one of the largest tangible Chemical Spaces for modern drug discovery. This release broadens structural diversity with novel...
Read on